BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21114784)

  • 1. The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia.
    Oh B; Butow P; Mullan B; Beale P; Pavlakis N; Rosenthal D; Clarke S
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):342-9. PubMed ID: 21114784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ezeome ER; Anarado AN
    BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
    Chrystal K; Allan S; Forgeson G; Isaacs R
    N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and alternative medicine practitioner consultations among those who have or have had cancer in a Norwegian total population (Nord-Trøndelag Health Study): prevalence, socio-demographics and health perceptions.
    Steinsbekk A; Adams J; Sibbritt D; Johnsen R
    Eur J Cancer Care (Engl); 2010 May; 19(3):346-51. PubMed ID: 19686272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of complementary and alternative medicine by patients with cancer in northern Turkey: analysis of cost and satisfaction.
    Aydin Avci I; Koç Z; Sağlam Z
    J Clin Nurs; 2012 Mar; 21(5-6):677-88. PubMed ID: 21714820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.
    Tasaki K; Maskarinec G; Shumay DM; Tatsumura Y; Kakai H
    Psychooncology; 2002; 11(3):212-20. PubMed ID: 12112481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of traditional, complementary and alternative medicine in Sri Lankan cancer care: results from a survey of 500 cancer patients.
    Broom A; Wijewardena K; Sibbritt D; Adams J; Nayar KR
    Public Health; 2010 Apr; 124(4):232-7. PubMed ID: 20363486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy.
    Swarup AB; Barrett W; Jazieh AR
    Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of complementary and alternative medicine among cancer patients in Israel.
    Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
    Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.
    Dy GK; Bekele L; Hanson LJ; Furth A; Mandrekar S; Sloan JA; Adjei AA
    J Clin Oncol; 2004 Dec; 22(23):4810-5. PubMed ID: 15570083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors.
    Humpel N; Jones SC
    Eur J Cancer Care (Engl); 2006 Sep; 15(4):362-8. PubMed ID: 16968318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine (CAM) among hospitalised patients: an Australian study.
    Shorofi SA; Arbon P
    Complement Ther Clin Pract; 2010 May; 16(2):86-91. PubMed ID: 20347839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of complementary and alternative medicine among women with gynecologic cancers.
    Swisher EM; Cohn DE; Goff BA; Parham J; Herzog TJ; Rader JS; Mutch DG
    Gynecol Oncol; 2002 Mar; 84(3):363-7. PubMed ID: 11855870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients.
    Tatsumura Y; Maskarinec G; Shumay DM; Kakai H
    Altern Ther Health Med; 2003; 9(3):64-71. PubMed ID: 12776477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.
    Montazeri A; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
    Eur J Cancer Care (Engl); 2007 Mar; 16(2):144-9. PubMed ID: 17371423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary and alternative medicine (CAM) and cancer: the kind face of complementary medicine.
    Ernst E
    Int J Surg; 2009 Dec; 7(6):499-500. PubMed ID: 19716449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taiwanese adult cancer patients' reports of using complementary therapies.
    Lu JH; Tsay SL; Sung SC
    Cancer Nurs; 2010; 33(4):320-6. PubMed ID: 20467307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
    Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
    Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.